| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 30/04/2024 | 00:40 | Business Wire | FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer | NYSE:PFE | Pfizer Inc |
| 30/04/2024 | 00:40 | Business Wire | TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer | NYSE:PFE | Pfizer Inc |
| 29/04/2024 | 12:45 | Business Wire | Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting | NYSE:PFE | Pfizer Inc |
| 26/04/2024 | 13:48 | IH Market News | Anglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More News | NYSE:PFE | Pfizer Inc |
| 26/04/2024 | 12:45 | Business Wire | U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B | NYSE:PFE | Pfizer Inc |
| 24/04/2024 | 22:37 | Business Wire | Pfizer Declares Second-Quarter 2024 Dividend | NYSE:PFE | Pfizer Inc |
| 24/04/2024 | 13:28 | IH Market News | Coca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More News | NYSE:PFE | Pfizer Inc |
| 22/04/2024 | 14:08 | Business Wire | European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options | NYSE:PFE | Pfizer Inc |
| 11/04/2024 | 16:00 | Business Wire | Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25 | NYSE:PFE | Pfizer Inc |
| 10/04/2024 | 13:13 | IH Market News | Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News | NYSE:PFE | Pfizer Inc |
| 09/04/2024 | 12:45 | Business Wire | Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease | NYSE:PFE | Pfizer Inc |
| 08/04/2024 | 18:44 | PR Newswire (US) | ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager | NYSE:PFE | Pfizer Inc |
| 26/03/2024 | 12:20 | IH Market News | Super Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest News | NYSE:PFE | Pfizer Inc |
| 21/03/2024 | 12:17 | IH Market News | Apple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market Updates | NYSE:PFE | Pfizer Inc |
| 20/03/2024 | 15:00 | Business Wire | Pfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with Analysts | NYSE:PFE | Pfizer Inc |
| 19/03/2024 | 12:33 | IH Market News | Unilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and More | NYSE:PFE | Pfizer Inc |
| 18/03/2024 | 12:10 | IH Market News | Apple & Google in Talks for Gemini AI on iPhone, Nvidia’s GTC Conference Today, and Latest News | NYSE:PFE | Pfizer Inc |
| 13/03/2024 | 09:00 | Business Wire | European Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease | NYSE:PFE | Pfizer Inc |
| 12/03/2024 | 11:45 | Business Wire | Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) | NYSE:PFE | Pfizer Inc |
| 05/03/2024 | 21:55 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:PFE | Pfizer Inc |
| 05/03/2024 | 16:00 | Business Wire | Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference | NYSE:PFE | Pfizer Inc |
| 05/03/2024 | 15:03 | IH Market News | Futures Pointing To Continued Weakness On Wall Street | NYSE:PFE | Pfizer Inc |
| 29/02/2024 | 23:40 | Business Wire | Pfizer Oncology Hosts Innovation Day, Highlighting Fully Integrated Organization, Robust Portfolio, and Strategic Priorities to Drive Long-Term Sustainable Growth | NYSE:PFE | Pfizer Inc |
| 29/02/2024 | 14:00 | Business Wire | Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults | NYSE:PFE | Pfizer Inc |
| 27/02/2024 | 15:14 | IH Market News | U.S. Stocks May Lack Direction Following Yesterday’s Modest Pullback | NYSE:PFE | Pfizer Inc |
| 23/02/2024 | 22:34 | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NYSE:PFE | Pfizer Inc |
| 23/02/2024 | 22:33 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NYSE:PFE | Pfizer Inc |
| 22/02/2024 | 19:17 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NYSE:PFE | Pfizer Inc |
| 19/02/2024 | 13:45 | Business Wire | European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis | NYSE:PFE | Pfizer Inc |
| 15/02/2024 | 16:00 | Business Wire | Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day | NYSE:PFE | Pfizer Inc |